Invention Grant
- Patent Title: Dengue serotype 2 attenuated strain
- Patent Title (中): 登革热血清型2减毒株
-
Application No.: US11453344Application Date: 2006-06-15
-
Publication No.: US07641908B2Publication Date: 2010-01-05
- Inventor: Richard Kinney , Claire Y. H. Kinney , Véronique Barban , Jean Lang , Bruno Guy
- Applicant: Richard Kinney , Claire Y. H. Kinney , Véronique Barban , Jean Lang , Bruno Guy
- Applicant Address: FR Lyons US GA Atlanta
- Assignee: Sanofi Pasteur,Center for Disease Control and Prevention
- Current Assignee: Sanofi Pasteur,Center for Disease Control and Prevention
- Current Assignee Address: FR Lyons US GA Atlanta
- Agency: Stites & Harbison PLLC
- Agent B. Aaron Schulman; Terry L. Wright
- Main IPC: A61K39/12
- IPC: A61K39/12
Abstract:
The invention relates to live attenuated VDV2 (VERO-Derived Vaccine Dengue serotype 2) strains which have been derived from the wild-type dengue-2 strain 16681 by passaging on PDK and Vero cells. The invention further relates to a vaccine composition which comprises a VDV2 strain.
Public/Granted literature
- US20070026016A1 Dengue serotype 2 attenuated strain Public/Granted day:2007-02-01
Information query
